LUDWIG ENTERPRISES, INC. appointed new CEO

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


New Directors. On November 28, 2023, the Company's Board of Directors (the "Board") appointed two new directors to the Board: (1) Marvin Hausman, M.D., the Company's current Chief Executive Officer; and (2) Scott J. Silverman, the Company's current Chief Financial Officer. Such appointments were effective immediately. There exist no family relationships among any of the Company's directors or executive officers.


Certain information concerning the backgrounds of Dr. Hausman and Mr. Silverman is set forth below.


Marvin S. Hausman, M.D. has served as our Chief Executive Officer and Chief Science Officer since September 5, 2023, after serving as a key consultant to our company since July 2022. Dr. Hausman is an Immunologist and Board-Certified Urological Surgeon with more than 30 years of drug research and development experience with various pharmaceutical companies, including Bristol Myers International, Mead Johnson Pharmaceutical Co., E.R. Squibb, Medco Research, and Axonyx. An accomplished executive with domestic and international experience, Dr. Hausman successfully executed acquisitions of breakthrough medical technology, in conjunction with formation, funding and launch of several corporations. He is a co-founder of Medco Research Inc., a NYSE biopharmaceutical company acquired by King Pharmaceutical Inc. He is a founder of Axonyx Inc., acquired by Torrey Pines Therapeutics, Inc. He is a founder of Entia Biosciences, Inc., which designs and develops natural organic antioxidant food-based products to be used as nutritional supplements in humans and animals. He is Founder and President of Northwest Medical Research Partners, Inc., a company specializing in the identification and acquisition of breakthrough pharmaceutical and nutraceutical products. Dr. Hausman is a Member of the Board of Governors of New York University School of Medicine Alumni Association. 


Scott J. Silverman is one of the founders, and serves as President and CEO, of EverAsia Financial Group, which grew into a multi-national corporate financial management and advisory firm serving clients in the United States and Asia, and JJL Capital Management, a private equity firm that focuses its investments in the hospitality, construction, real estate and healthcare sectors. He also serves as the CFO of HealthSnap, Inc., a healthcare company with a Virtual Care Management (VCM) platform on the cutting edge of remote patient monitoring and chronic care management.


Previously, Mr. Silverman served as the CFO of Sidus Space, Inc., a publicly traded Space-as-a-Service company in which capacity he oversaw its IPO, and Riverside Miami, LLC, a mixed-use restaurant and entertainment project in Miami, Florida. Mr. Silverman has orchestrated investor exits for multiple companies, including direct participation in taking 17 companies public. He has a bachelor's degree in finance from George Washington University and a master's degree in accounting from NOVA Southeastern University.


Resignation of Officer. On November 30, 2023, Thomas Terwilliger resigned as Chief Operating Officer of the Company. In his letter of resignation, Mr. Terwilliger advised that his resignation was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.


The foregoing description of Mr. Terwilliger's letter of resignation is qualified in its entirety by the full text thereof, which is filed as Exhibit 17.1 hereto and incorporated by reference in this report.